A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants

NCT06673927 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: YZJ-1139
DRUG: YZJ-1139
DRUG: Placebo

Sponsor

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.